BSWRI researcher Erxi Wu, Ph.D. recently co-authored a paper published in Therapeutic Advances in Medical Oncology, which offered research perspectives on the targeting of SLIT/ROBO pathways. The paper, titled “Targeting the SLIT/ROBO pathway in tumor progression: molecular mechanisms and therapeutic perspectives” was written in collaboration with researchers at Xi’an Jiaotong University in China.
New research results from a COAPT study examined the effect MitraClip had on heart failure patients.
Baylor Scott & White Medical Center in Temple has opened enrollment on a study designed to help characterize the prevalence and distribution of lipoprotein(a) Lp(a), levels among patients with established cardiovascular disease (CVD).
Baylor Scott & White Heart & Vascular Hospital – Dallas is currently enrolling patients for a prospective, multicenter, single-arm, global investigational device exemption (IDE) study to evaluate the safety and effectiveness of the Shockwave Coronary IVL System in de novo, calcified, stenotic coronary arteries prior to stenting. Disrupt CAD III is being conducted as a staged pivotal study.
Baylor Scott & White All Saints Medical Center – Fort Worth is currently enrolling patients for a study designed to assess the impact of the Multi Point Pacing (MPP) feature at 12 months in the treatment of patients not responding to standard Cardiac Resynchronization Therapy (CRT) after 6 months.
